Koers Elite Pharmaceuticals Inc OTC Bulletin Board
Aandelen
US28659T2006
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2022 | 32,26 mln. 30 mln. | Omzet 2023 | 34,16 mln. 31,77 mln. | Marktkapitalisatie | 29,4 mln. 27,35 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 8 mln. 7,44 mln. | Nettowinst (verlies) 2023 | 3 mln. 2,79 mln. | EV/omzet 2022 | 0,92 x |
Nettoliquiditeiten 2022 | 5,75 mln. 5,35 mln. | Nettoliquiditeiten 2023 | 3,94 mln. 3,67 mln. | EV/omzet 2023 | 0,75 x |
K/w-verhouding 2022 |
4,73
x | K/w-verhouding 2023 |
9,34
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 77,76% |
Recentste transcriptie over Elite Pharmaceuticals Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nasrat Hakim
CEO | Chief Executive Officer | 63 | 01-08-13 |
Carter Ward
DFI | Director of Finance/CFO | 59 | 01-07-09 |
Christopher Dick
PSD | President | 69 | 01-11-02 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jeffrey Whitnell
BRD | Director/Board Member | 68 | 23-10-09 |
Barry Dash
BRD | Director/Board Member | 93 | 01-04-05 |
Davis Caskey
BRD | Director/Board Member | 76 | 28-04-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,67% | 43,74 mld. | |
+21,99% | 22,26 mld. | |
+16,41% | 14,9 mld. | |
+9,03% | 13,39 mld. | |
+40,48% | 12,12 mld. | |
-9,64% | 6,92 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+12,41% | 5,47 mld. |
- Beurs
- Aandelen
- Koers ELTP
- Koers